myopia
Conditions
Interventions
FDR group:During the two-year follow-up period, all subjects received once-daily text message reminders.
FDR - CON group:During the two-year follow-up period, in the first year, all subjects received once-daily text message reminders
in the second year, the subjects no
TR group:During the second year of follow-up, all subjects received a text message reminder when they failed to complete treatment on time.
TR - CON group:During the second year of follow-up, in the first half, all subjects received a text message reminder when they failed to complete treatment on time,
CON group:During the second year of follow-up, none of the subjects received text message reminders.
CON - TR group:During the two-year follow-up period, subjects did not receive any text message reminders in the first year
in the second year, subjects received a t
Sponsors
Tianjin Medical University Eye Hospital
Eligibility
Sex/Gender
All
Age
6 Years to 16 Years
Inclusion criteria
Inclusion criteria: 1. School-aged children aged 6 to 16 years, regardless of gender; 2. Spherical equivalent refraction ranging from -6.00D to +0.75D; 3. No other organic diseases affecting vision in either eye; 4. Participants and their guardians are able to understand the purpose of this study and sign the informed consent form. Participants must be able to comply with the treatment and relevant ophthalmic examinations and agree not to adopt any other myopia prevention and control measures outside the study protocol throughout the entire study period;
Exclusion criteria
Exclusion criteria: 1. Those who have previously received myopia prevention and control treatments, such as the use of anticholinergic drugs like atropine within the past 3 months, or have participated in other studies related to functional frame glasses, functional soft/hard contact lenses (orthokeratology lenses), etc. 2. History of photosensitivity, glaucoma, Posner-Schlossman syndrome, ocular hypertension, or the presence of macular lesions or damage in the fundus. 3. Patients with concurrent systemic diseases involving the heart, liver, kidneys, etc., as well as those with congenital hereditary myopia. 4. Patients with concurrent eye injuries, manifest strabismus, surgical eyes, or chronic eye diseases such as allergic conjunctivitis. 5. Patients with a history of other eye conditions, including entropion and trichiasis, severe corneal or conjunctival infections, etc. 6. Patients with concurrent neurological diseases, or those with allergies or contraindications to atropine or other therapeutic drugs. 7. Patients with immune system or systemic diseases such as albinism, psoriasis, nephrotic syndrome, systemic lupus erythematosus, diabetes, etc. 8. Other conditions deemed by the investigator as unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change in axial length; | — |
Secondary
| Measure | Time frame |
|---|---|
| change in spherical equivalent refraction;Changes in choroidal thickness; | — |
Countries
China
Contacts
Public ContactWei Ruihua
Tianjin Medical University Eye Hospital
Outcome results
None listed